Long-Term Cardiovascular Risks Linked to ADHD Medications

JAMA Network

About The Study: Longer cumulative duration of attention-deficit/hyperactivity disorder (ADHD) medication use was associated with an increased risk of cardiovascular disease, particularly hypertension and arterial disease, compared with nonuse in this study of 278,000 individuals in Sweden ages 6 to 64 who had an incident ADHD diagnosis or ADHD medication dispensation. These findings highlight the importance of carefully weighing potential benefits and risks when making treatment decisions about long-term ADHD medication use. Clinicians should regularly and consistently monitor cardiovascular signs and symptoms throughout the course of treatment.

Authors: Zheng Chang, Ph.D., and Le Zhang, Ph.D., of the Karolinska Institutet in Stockholm, are the corresponding authors.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(10.1001/jamapsychiatry.2023.4294)

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.